We are live on
!
Find out more
VAM
Visium Asset Management Portfolio holdings
AUM
$1.43B
1-Year Est. Return
3.58%
This Fund
S&P 500
This Quarter
Est. Return
+13.68%
1 Year Est. Return
-3.58%
3 Year Est. Return
+100.3%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$6.18B
AUM Growth
+$1.08B
(+21%)
Cap. Flow
+$404M
Cap. Flow
% of AUM
6.55%
Top 10 Holdings %
Top 10 Hldgs %
31.51%
Holding
1,163
New
297
Increased
261
Reduced
271
Closed
313
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ENDP
Endo International plc
ENDP
|
+$197M |
| 2 |
AGN
Allergan plc
AGN
|
+$135M |
| 3 |
Bausch Health
BHC
|
+$129M |
| 4 |
CVS Health
CVS
|
+$107M |
| 5 |
McKesson
MCK
|
+$94.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan Inc
AGN
|
+$286M |
| 2 |
ICPT
Intercept Pharmaceuticals, Inc.
ICPT
|
+$225M |
| 3 |
Gilead Sciences
GILD
|
+$86.1M |
| 4 |
Perrigo
PRGO
|
+$79.4M |
| 5 |
Cardinal Health
CAH
|
+$74.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 53.16% |
| 2 | Consumer Discretionary | 5.06% |
| 3 | Energy | 4.01% |
| 4 | Utilities | 3.23% |
| 5 | Financials | 3.21% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CYNO
201
DELISTED
Cynosure, Inc. Class A
CYNO
| $5.87M | 0.1% |
+200,200
| New | +$5.68M |
|
|
AMRN
202
Amarin Corp
AMRN
$299M
| $5.86M | 0.09% |
161,862
-3,138
| -2% | -$117K |
|
203
Terex
TEX
$7.18B
| $5.81M | 0.09% |
131,200
+18,800
| +17% | +$790K |
|
|
HTWR
204
DELISTED
HEARTWARE INTERNATIONAL INC COM STK (DE)
HTWR
| $5.71M | 0.09% |
60,898
-86,435
| -59% | -$8.41M |
|
|
QGENF
205
DELISTED
QIAGEN NV
QGENF
| $5.69M | 0.09% |
288,193
-256,782
| -47% | -$5.07M |
|
206
Service Corp International
SCI
$11.7B
| $5.61M | 0.09% |
282,335
+180,426
| +177% | +$3.31M |
|
|
SWY
207
DELISTED
SAFEWAY INC
SWY
| $5.55M | 0.09% |
167,911
-292
| -0.2% | -$9.06K |
|
208
Acadia Pharmaceuticals
ACAD
$4.43B
| $5.55M | 0.09% |
227,936
-878,686
| -79% | -$22.2M |
|
|
EPL
209
DELISTED
EPL OIL & GAS, INC COMMON STK
EPL
| $5.51M | 0.09% |
+142,688
| New | +$4.36M |
|
|
HOUS
210
DELISTED
Anywhere Real Estate
HOUS
| $5.46M | 0.09% |
125,534
+15,550
| +14% | +$725K |
|
|
CTRA
211
DELISTED
Coterra Energy
CTRA
| $5.42M | 0.09% |
159,972
+132,572
| +484% | +$4.9M |
|
|
HES
212
DELISTED
Hess
HES
| $5.41M | 0.09% |
65,288
+17,662
| +37% | +$1.4M |
|
213
Repligen
RGEN
$7.96B
| $5.4M | 0.09% |
+420,000
| New | +$6.02M |
|
214
Bruker
BRKR
$9.57B
| $5.38M | 0.09% |
236,077
-1,918
| -0.8% | -$41.8K |
|
|
INFI
215
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
| $5.35M | 0.09% |
450,000
-501,852
| -53% | -$6.73M |
|
216
Fossil Group
FOSL
$293M
| $5.35M | 0.09% |
45,845
+41,159
| +878% | +$4.8M |
|
217
Masco
MAS
$14.1B
| $5.34M | 0.09% |
273,725
+128,161
| +88% | +$2.53M |
|
|
PARA
218
DELISTED
Paramount Global Class B
PARA
| $5.31M | 0.09% |
85,964
+76,356
| +795% | +$4.82M |
|
|
CXO
219
DELISTED
CONCHO RESOURCES INC.
CXO
| $5.31M | 0.09% |
+43,348
| New | +$4.77M |
|
|
MNDT
220
DELISTED
Mandiant, Inc. Common Stock
MNDT
| $5.29M | 0.09% |
+85,914
| New | +$6.09M |
|
|
CTRA
221
CALL
DELISTED
Coterra Energy
CTRA
| $5.24M | 0.08% |
+154,600
| New | +$5.71M |
|
222
Melco Resorts & Entertainment
MLCO
$2.22B
| $5.23M | 0.08% |
135,390
-77,184
| -36% | -$3.21M |
|
223
Cytokinetics
CYTK
$10.5B
| $5.23M | 0.08% |
550,200
+382,700
| +228% | +$3.46M |
|
|
CHTP
224
DELISTED
CHELSEA THERAPEUTICS INT'L LTD
CHTP
| $5.14M | 0.08% |
931,134
-568,866
| -38% | -$2.86M |
|
|
RTN
225
DELISTED
Raytheon Company
RTN
| $5.14M | 0.08% |
52,003
+48,983
| +1,622% | +$4.65M |
|
Similar funds
FBNAT
CPS
LH
CPM
VFS
ZA
FVFIGP
WA
Visium Asset Management's Q1 2014 Portfolio in Review
As of Q1 2014, Visium Asset Management held 1,163 positions worth $6.18B, up 21% from $5.09B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Visium Asset Management deployed $404M of net new capital in Q1 2014, opening 297 new positions and adding to 261 existing holdings. Its largest new stake was Regeneron Pharmaceuticals: 286,563 shares worth $86M.
By sector, the portfolio is most concentrated in Healthcare at 53% of assets, down from 54% a quarter earlier, followed by Consumer Discretionary and Energy.
On the sell side, the largest reduction was Allergan Inc, an estimated $286M trimmed.
- Visium Asset Management's largest Q1 2014 buy was Regeneron Pharmaceuticals: 286,563 shares worth $86M.
- Visium Asset Management added most to Endo International plc in Q1 2014, an estimated $197M increase.
- Visium Asset Management's biggest Q1 2014 reduction was Allergan Inc, cutting an estimated $286M.
- Visium Asset Management fully exited Momenta Pharmaceuticals, Inc. in Q1 2014, selling an estimated $64M.
- Visium Asset Management's ten largest holdings make up 32% of its $6.18B portfolio in Q1 2014.
- Visium Asset Management opened 297 new positions and closed 313 in Q1 2014.
- Visium Asset Management's portfolio value rose 21% quarter-over-quarter to $6.18B.
Based on Visium Asset Management's 13F filing for Q1 2014, filed 15 May 2014.